The Valley Desk

NCT01282424 · Interventional trial

Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas

Overall registry status Completed

Phase 2

Conditions Follicular Lymphoma, Lymphoplasmacytic Lymphoma, Marginal Zone Lymphoma, Small Lymphocytic Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov